Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease glioma
Comorbidity C0007131|nsclc
Sentences 1
PubMedID- 22588882 At equivalent doses, erlotinib achieved lower kinase-site occupancy in glioma-derived egfrviii compared with nsclc-derived egfr mutants.

Page: 1